(Q33332444)

English

Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO).

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO). (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

based on heuristic

inferred from title

4

object named as

N Fazio

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

11

object named as

F Cavalli

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

author name string

A D Roth

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

R Maibach

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

G Martinelli

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M S Aapro

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

O Pagani

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

R Morant

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M M Borner

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

R Herrmann

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

H Honegger

10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

P Alberto

12

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

M Castiglione

13

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A Goldhirsch

14

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

publication date

1 March 2000

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

301-306

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Screening for gastric cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of combination chemotherapy in unresectable gastric cancer. The Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF).

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for esophagogastric adenocarcinoma: Response, toxicity, quality of life, and survival

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for advanced gastric cancer: where do we stand?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere).

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of docetaxel (Taxotere) in patients with adenocarcinoma of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: the Eastern Cooperative Oncology Group (ECOG) results of protocol E1293.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Optimal two-stage designs for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin, doxorubicin and etoposide (PAV) in advanced gastric carcinoma: the SAKK experience. Swiss Group for Clinical Cancer Research (SAKK).

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for Clinical Research

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II Trial of Etoposide (V), Adriamycin (A), and Cisplatinum (P) in Patients with Metastatic Gastric Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Etoposide, doxorubicin, and cisplatin chemotherapy for advanced gastric adenocarcinoma: results of a phase II trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

FAMTX versus etoposide, doxorubicin, and cisplatin: a random assignment trial in gastric cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

The timing and sequence of multiple device-related complications in patients with indwelling subcutaneous ports

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral neuropathy induced by combination chemotherapy of docetaxel and cisplatin

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008342013224

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008342013224

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33332444&oldid=1614129012"